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Objective. The aim was to determine eﬃcacy and safety of a surgical method to reduce adult height in extremely tall adolescents.
Methods. Data for all girls (n = 12) and boys (n = 9) in our center subjected to bilateral percutaneous epiphysiodesis around the
knee who had reached ﬁnal height were included. Final height predictions were based on hand and wrist X-rays before surgery.
Results. When compared to prediction, adult height was reduced by 4.1 ± 0.7cm in treated girls (P<. 001) and 6.4 ± 0.7cmin
treated boys (P<. 001) corresponding to a 33.6 ± 3.4% and 33.6 ± 4.2% reduction of remaining growth, respectively. Besides
mild to moderate postoperative pain reported in 9 operated individuals, no other side eﬀects were reported. Postoperative X-rays
conﬁrmedgrowthplateclosureandabsence oflegangulations.Conclusions. Bilateral epiphysiodesis is an eﬀectiveandsafemethod
to reduce adult height in extremely tall girls and boys.
1.Introduction
In Sweden, a common deﬁnition of extreme tall stature is an
adult height exceeding 200cm for boys and 185cm for girls
corresponding to approximately 3SD above the mean. Tall
statureismostoftencausedbygeneticfactors(constitutional
tallstature).However,anunderlyingdisordermustalwaysbe
considered in tall individuals as many of them need special
medical attention. These include homocysteinuria, growth
hormone excess, and various syndromes such as Klinefelter,
Sotos, Marfan, and Beckwith-Wiedemann syndrome [1, 2].
Extreme tall stature is a common reason for referral
to pediatric endocrinology centers in northern European
countries. Patients and their families often express a strong
desire for intervention aiming to reduce adult height. The
treatment options for children with extreme tall stature
are limited. To reduce ﬁnal height (FH), boys have been
treated with high-dose testosterone and girls with high-dose
estradiol [3, 4]. The treatment was introduced already in
1956, but its use has decreased dramatically in the last two
decades, possibly due to a change in attitude towards tall
stature and concerns of long-term complications [5]. In a
meta-analysis study, hormonal treatment was only found to
reduce ﬁnal height if initiated before a bone age of around 14
yrs in both genders [6]. It was suggested that administration
of sex steroids after this age causes extra growth instead of
growth inhibition.
Undesired side eﬀects are commonly reported in patients
undergoing hormonal treatment for tall stature. For boys,
one of the most common complaints reported is acne.
Other documented side eﬀects are weight gain, muscle
ache, gynecomastia, hypertrichosis, behavioural changes,
and aggressiveness [7, 8]. For girls, side eﬀects include
nausea, headache, elevated serum triglycerides, calf cramps,
and weight gain [8–10]. More serious concerns with the
treatment include a possible increased risk of venous
thrombosis. Studies have shown changes in coagulation
parameters [11] although no studies have been able to show2 International Journal of Pediatric Endocrinology
an increased risk of venous thrombosis [12]. There is also a
fear of a further increased risk of breast cancer [4, 9, 13]a n d
decreased fertility [4]. One study from Australia shows that
women who have been on high-dose oestrogen treatment
to reduce their ﬁnal height are more likely to have tried
for over a year to get pregnant (relative risk 1.80, 95%
CI 1.40–2.30) and to have taken fertility drugs (relative risk
2.05, 95% CI 1.34–3.04). They are also less likely to conceive
in any given menstrual cycle although the possibility of
conceivingatallisonlyslightlydecreased,possiblyduetothe
availability of fertility treatments. Because of the various side
eﬀects associated with hormonal treatment and sometimes
limited eﬃcacy, an alternative treatment modality is desired.
Surgical epiphysiodesis performed around the knee has
for many years been used to treat leg length discrepancies
[14]. In extremely tall boys, the use of bilateral percutaneous
epiphysiodesis was recently reported to reduce adult height
by approximately 5cm when performed at a mean bone
age of 13.9 years [15]. However, it is important to point
out that still this is a controversial treatment as it is being
performedinhealthyadolescentsandfurthersupportivedata
are lacking.
The aim of our study was to determine the eﬃcacy and
safety of bilateral epiphysiodesis around the knee when per-
formed to limit further growth in extremely tall adolescent
girls and boys. We included radiological assessments of bone
growth and bone angles and a reference group of untreated
extremely tall subjects to document the eﬃcacy and safety of
bilateral percutaneous epiphysiodesis.
2.SubjectsandMethods
2.1. Study Subjects. All study subjects have been followed at
the Pediatric Endocrine Clinic at Astrid Lindgren Children’s
Hospital, Karolinska University Hospital, Stockholm, Swe-
den. After approval by the local ethics committee, patients
have been recruited since year 1997. All tall girls and boys
who fulﬁlled the inclusion criteria (Table 1)w e r eo ﬀered
to undergo bilateral percutaneous epiphysiodesis around
the knee. Informed consents were given by all patients
who participated in the study and their parents. Until
January 2009, 49 patients (21 boys and 28 girls) have
undergone surgery. Out of these, 21 subjects (12 girls
and 9 boys) had reached ﬁnal height, and data from all
these subjects are presented in this paper. All patients had
been diagnosed with constitutional tall stature except three
patients with Marfan syndrome and one with Klinefelter
syndrome. Most of the patients were midpubertal at time
of surgery, the girls generally slightly less advanced in their
pubertal development (range B2–B4) than the boys (G2–
G5). In the constitutionally tall patients, the midparental
height (deﬁned as the average of the parent’s heights −6.5cm
for girls and +6.5cm for boys) was calculated. Midparental
height was 177.7 ± 1.9cm in girls and 190.5 ± 1.1cm
in boys (corresponding to +1.7SDS and +1.5SDS, resp.).
Two patients with constitutional tall stature were excluded
from this calculation, one with a parent who had received
hormonal treatment for tall stature and another with a
parent diagnosed with Marfan syndrome.
Table 1: Inclusion criteria to be oﬀered bilateral percutaneous
epiphysiodesis.
(i) Final height prediction of at least 200cm in boys and 185cm in
girls
(ii) Remaining predicted growth of at least 8cm
(iii) Relatively long legs (relative sitting height below the mean)
(iv) A strong patient desire to undergo the treatment
At each occasion, height and sitting height were mea-
sured by an experienced professional using a Harpenden
stadiometer. Bone age maturation was determined by two
blinded experts on an X-ray ﬁlm of the left hand and
wrist using the atlas of Greulich and Pyle [16]. Final height
predictions were made according to the Bailey and Pinneau
tables [17]. To further verify the eﬃcacy and safety of the
treatment, hip-knee-ankle (HKA) angles and leg lengths
(femur and tibia lengths) were measured digitally on plain
X - r a yﬁ l m sb e f o r es u r g e r ya n da tﬁ n a lh e i g h t .D u et o
technical and practical problems, complete information for
HKA-angle was only available in 15 patients and for leg
length in 9 patients.
2.2. Validation of the Final Height Prediction Error in
Untreated Tall Subjects. To validate the precision of our
ﬁnal height predictions, we recruited 17 untreated subjects
(12 girls and 5 boys), all diagnosed with constitutional tall
stature. They had been through a similar workup as the
operated patients, including a hand X-ray but had never
undergone treatment. At time of ﬁrst visit, the mean age was
13.6 ± 0.4yrs in girls and 15.2 ± 0.8yrs in boys while the
mean bone age was 12.9 ± 0.1yrs in girls and 14.6 ± 0.6yrs
in boys. These reference subjects did not signiﬁcantly diﬀer
from the study population (Table 3). The mean height at
this initial workup was 175.9 ± 1.1cm in girls and 188.5 ±
5.9cm in boys. Based on evaluation of a hand and wrist X-
ray ﬁlm obtained, the ﬁnal height predictions were 184.0 ±
1.0cm and 200.7 ± 2.2cm in girls and boys, respectively.
When comparing predicted ﬁnal height with achieved adult
height, we found that girls were overpredicted by a mean of
0.2±0.6cmandboysoverpredictedbyameanof1.3±1.8cm.
In addition, we recruited another group of 12 young
normal height adults (age 20–40 years; 11 females and
1 male) that were measured twice in a day with an eight-
hour interval (at 8am and 4pm) with the aim to quantify
the well-known reduction of height that normally occurs
throughout the day. In these subjects, the mean loss in
height over 8 hours was 0.7 ± 0.1cm. When validating the
ﬁnal height predictions, we compensated for the calculated
hourly loss in height over the day (0.092 ± 0.012cm/hour)
to correct for any error caused by a diﬀerence in time
between measurements performed in individual subjects. If
making this correction, ﬁnal height predictions in the tall
untreated girls were equal to the achieved adult heights for
girls (0.1cm) while boys were still slightly overpredicted
(0.5cm). As the mean prediction error was so small, we
decided not to correct for this when calculating the eﬃcacy
of the operation in the study population.International Journal of Pediatric Endocrinology 3
2.3. Surgical Technique. Growth arrest was achieved by bilat-
eral percutaneous epiphysiodesis performed under general
anaesthesia. A tourniquet was applied to reduce bleeding.
The growth plates of the distal femur and proximal tibia
and ﬁbula were identiﬁed using an X-ray image intensiﬁer
(C-arm). Through one cm incisions at the lateral aspects
of the femoral and tibial growth plates, epiphysiodesis
was performed with a drill (8mm) and oval angulated
curettes (5–7mm). The growth plate of the ﬁbula was
curetted with a 3mm straight oval curette through the tibial
incision from an anterior direction to avoid damage to
the peroneal nerve. The curettage was controlled by short
snapshots with the image intensiﬁer. Between 25% and 50%
of each growth plate was removed to induce the formation
of bony bridges across the physis to ensure complete
elimination of growth. Curetted bone tissue was removed
from the subcutaneous tissue to avoid extraosseous bone
formation. Local anaesthesia was injected adjacent to the
skin incisions. The total operation time was approximately
45 minutes per leg.
In the here reported patients, postoperative analgesia was
supported by continuous femoral nerve blockage for 24–48
hours. Additional postoperative analgesia was achieved by
oral paracetamol and nonsteroidal anti-inﬂammatory drugs.
More recently, we have discontinued to apply femoral nerve
blockagewhichhasfacilitatedthepostoperativemobilization
with no increase in the reports of postoperative pain
(data not shown).
To achieve full range of knee movement, physiotherapy
and full weight bearing with crutches was initiated within
24 hours after surgery. Patients were discharged from the
hospital when they were able to ambulate and bend their
knees at least 90 degrees which typically occurred on the 2nd
or 3rd day postoperatively. As a precaution, patients were
advised to avoid strenuous physical activities for 4 weeks
(no running or jumping).
2.4. Followup of Study Subjects. Twelve months postoper-
atively, total destruction of operated growth plates was
conﬁrmed on plain knee X-ray ﬁlms. Total height, sitting
height, and arm span were measured every 12 months
after surgery until adult height was reached. Leg length was
calculated as the diﬀerence between measured total height
and sitting height. In addition, leg length was measured
radiologically both preoperatively and when adult height
had been reached. According to our deﬁnition, adult height
was reached when the calculated growth velocity was less
than 0.5cm per year when assessed over a minimum of
a 6-month interval. When adult height had been reached,
each patient went through a work up which included clinical
examination focusing on the eﬃcacy and long-term safety
of the treatment. In addition, plain digital X-ray ﬁlms were
taken of both legs to determine if any angulation (hip-knee-
ankle angle) or leg length discrepancy had developed as a
consequence of the previous operation.
2.5. Statistics. R e s u l t sa r er e p o r t e da sm e a n s± SEM. Stu-
dent’s t-test was applied and when normality test failed
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Figure 1: Predicted growth (Pred growth), increase in height (Inc
Ht), increase in sitting height (inc SH), and increase in leg length
(leg growth) from time of surgery.
Wilcoxon Signed Rank test was used to analyse treatment
eﬀects. The relationship between pairs of variables was
assessed by Pearson’s correlation. P-values of <. 05 were
considered statistically signiﬁcant.
3. Results
3.1. Baseline Characteristics of the Study Population. The
baseline characteristics of individual subjects are detailed in
Table 2. Average height at surgery, predicted ﬁnal height, and
achieved ﬁnal height for the study population are shown
in Table 3. Mean predicted ﬁnal height at time of surgery
corresponded to +3.8±0.2SDS in girls and +3.8±0.3SDS in
boys. Then, the remaining predicted growth (ﬁnal predicted
height subtracted by height at surgery) was 11.9 ± 1.2cmin
girls and 17.9 ±2.3cminboys(Figure 1).
3.2. Treatment Eﬀect. In patients who underwent bilateral
percutaneous epiphysiodesis, the mean achieved ﬁnal
height was 186.4±0.8cm in girls and 199.1±1.5cminboys
(Table 3)correspondingto+3.1±0.1SDSand+2.8±0.2SDS,
respectively. Figure 2 illustrates the distribution of height
reductions versus initial predictions for all treated patients.
The mean reduction of ﬁnal height versus initial prediction
at time of surgery was 4.1 ± 0.7cm in girls (P<. 001) and
6.4 ± 1.2cm in boys (P<. 001) corresponding to growth
reductions of 33.8 ± 3.4% and 33.6 ± 4.2%, respectively
(Table 3). As expected, after surgery most of the growth
occurred in the upper body segment (Figure 1). The mean
increment in sitting height was 7.7 ± 0.7cm in girls and
10.4±1.0cm in boys, respectively, while the mean leg growth
(increase in total height subtracted by increase in sitting
height) was only 0.1±0.2cmingirlsand1.1±0.4cminboys
(Figure 1). In the patients where leg growth was assessed
radiologically, mean femoral growth was 0.4 ± 0.2cm while
mean tibial growth was 0.7 ± 0.2cm. Altogether, the men4 International Journal of Pediatric Endocrinology
Table 2: Clinical data for individual patients.
Patient no CA at op BA at op Puberty at op Height at op FPH at op FH PFH-FH Diagnosis
Females
1 14.7 12.2 B2 179.7 191.7 186.9 4.8 CTS
2 13.8 12.8 B3 179.5 189.9 183.9 6.0 CTS
3 13.6 13.0 B2 182.2 190.7 187.8 2.9 CTS
4 13.5 13.0 B3 178.0 186.0 182.9 3.1 CTS
5 12.5 10.2 B2 176.0 199.8 189.8 10.0 CTS
6 13.0 12.7 B4 181,1 191.0 189.5 1.5 CTS
7 13.1 12.0 B2 180.0 193.5 189.7 3.8 CTS
8 11.6 12.6 B3 181.0 189.9 187.0 2.9 CTS
9 12.7 12.5 B3 175.7 185.4 182.8 2.6 Marfan
10 13.4 12.6 B2 177.3 190.2 184.9 5.3 CTS
11 11.8 11.5 B2 173.6 188.7 183.5 5.2 Marfan
12 13.7 12.5 B3 180.0 189.7 188.2 1.5 CTS
Males
13 16.5 14.3 G5 192.4 205.1 201.2 3.9 CTS
14 15.2 14.0 G3 183.1 196.0 191.7 4.3 CTS
15 14.2 14.5 G4 188.4 198.6 198.3 0.3 CTS
16 14.7 12.9 ND 185.5 211.2 200.5 10.7 CTS
17 13.7 14.2 G5 199.5 212.8 208.5 4.3 CTS
18 13.7 13.9 G3 187.8 207.0 199.0 8.0 CTS
19 14.5 14.1 G4 189.0 204.0 197.5 6.5 CTS
20 12.3 12.3 G1 175.3 205.5 195.3 10.2 Marfan
21 12.2 13.8 G5 187.9 209.6 200.2 9.4 Klinfelter
Chronological age (CA, yrs), bone age (BA, yrs), puberty (Tanner pubertal stage, breast (B) for girls and gonad (G) for boys), height (cm), and predicted ﬁnal
height (PFH, cm) at time of epiphysiodesisoperation (op). Final height (FH, cm) and individual diagnosis(constitutional tall stature (CT), Marfan Syndrome
(Marfan), and Klinefelter Syndrome (Klinefelter)).
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Figure2:Distributionofpatientsbasedonheightreductionsversus
predictions in girls and boys.
leg growth (femur + tibia growth) from surgery until ﬁnal
height was 1.2 ±0.1cm(n = 9) as measured by X-ray.
In boys, ﬁnal adult height was reduced by 3.9–10.7cm
except for one single patient who had a reduction of only
0.3cm. In this patient, the upper body growth after surgery
was 9.0cm while leg growth was only 0.9cm. Except for
one boy with Marfan syndrome (subject no. 20; Table 2), no
patient showed a leg growth exceeding 1.2cm after surgery.
In this boy, leg growth was 3.3cm while his upper body
segment increased by 16.7cm resulting in a 10.2cm reduc-
tion of adult height compared to the initial prediction. An
X-rayobtained12monthsaftersurgeryclearlydemonstrated
that his distal tibia growth plates were still completely open
while his operated proximal tibia and distal femur growth
plateswere,asexpected,fused.Whenexcludingpatientswith
primary growth disorders (three with Marfan and one with
Klinefelter syndrome), mean leg growth after surgery was
only 0.4 ± 0.2cm and if analyzed separately 0.0 ± 0.2cmin
girls and 0.9 ±0.3cminboys.
Figure 3 shows a clear negative correlation between bone
age at time of surgery and height reduction, a correlation
which was slightly stronger in boys (r =− 0.818; P<. 01)
than in girls (r =− 0.769, P<. 01). One of the female
patients was operated at an early bone age (10.1yrs). If this
patient is excluded, the negative correlation between bone
age and ﬁnal height reduction does not remain signiﬁcant
in girls.
3.3. Eﬀe c to nB o d yP r o p o r t i o n s . All operated girls except one
(Figure 4(a))a n da l lb o y se x c e p tt w o( Figure 4(b))h a daInternational Journal of Pediatric Endocrinology 5
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Figure 3: Reduction of predicted ﬁnal height as a function of
bone age at time of surgery. In both girls and boys, a negative
correlation was found between bone age and reduction of predicted
ﬁnal height.
relative sitting height below or well below the mean for age
showing that the subjects had relatively long legs at time of
surgery. The relative sitting height (SH) increased in every
treated girl (Figure 4(a))a n db o y( Figure 4(b)). In girls, the
mean relative SH was 51.9 ± 0.3% at FH versus 49.9 ± 0.3%
at operation (P<. 001). In boys, the relative SH at FH was
52.3±0.4%versus50.0±0.3%atoperation(P<. 001).Inthe
reference population, the mean relative SH at FH is 52.4% in
girls and 51.5% in boys [19]. Thus, in our operated patients,
relative SH at FH was still below the mean in girls and for
boys just slightly above the mean. For girls, average sitting
heightpercentagewas52.1inpatientstreatedbeforeand51.8
for those treated after a bone age of 12.5yrs. For boys, the
sitting height percentage was 51.8 in patients treated before
and 52.7 for those treated after a bone age of 14.0. From time
of surgery to ﬁnal height, mean arm span increased 3.2 ±1.6
and 4.0 ± 1.2cm more than height in girls (n = 9) and boys
(n = 7), respectively.
3.4. Safety. N os e r i o u ss i d ee ﬀects were reported in our
study. One patient had a postoperative superﬁcial cutaneous
infection which did not require treatment with antibiotics.
Nine patients reported postoperative pain from the site of
surgery and received oral analgesics (2–14 days). No patient
experienced pain after the ﬁrst two postoperative weeks.
Leg length discrepancy did not change signiﬁcantly
between time of surgery until ﬁnal height was achieved
(n = 10; P = .560). The mean leg length diﬀerence before
operation was 0.4 ± 0.1cm (range 0.0–0.9cm) and at ﬁnal
height 0.3 ± 0.1cm (0.0–1.0cm). To verify if any knee angu-
lations developed after surgery, radiologic measurements of
the Hip-Knee-Ankle (HKA) angle were performed before
surgery and at ﬁnal height. Between these two occasions, the
HKA angle was increased in seven patients (0.5–5.0 degrees)
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Figure 4: Relative sitting height as a function of bone age in girls
(a) and boys (b). For individual patients, the symbols illustrate
the relative sitting height and bone age at time of surgery and at
adultheight.Thehatchedhorizontallinesindicatethemeanrelative
sitting heights for the normal population.
while decreased in ten (0.5–5.0 degrees). In four of these
patients, the HKA angle was increased in one leg while
decreased in the other. None of them needed intervention or
experienced physical problems related to the surgery.
4. Discussion
We here report that bilateral percutaneous epiphysiodesis
performed around the knee eﬀectively inhibits further leg
growthwhenperformedinextremelytalladolescentgirlsand
boys. The operation was more eﬀective when performed at6 International Journal of Pediatric Endocrinology
Table 3: Clinical data for females and males.
CA at op (yrs) BA at op (yrs) Height at op (cm) PFH at op (cm) FH (cm) PFH-FH (cm)
Females 13.1 ±0.21 2 .3 ±0.2 178.7 ± 0.7 190.5 ±1.1 186.4 ±0.8a 4.1 ±0.7
Males 14.1 ±0.41 3 .8 ±0.2 187.7 ± 2.2 205.5 ±1.8 199.1 ±1.5a 6.4 ±3.5
Chronological age (CA), bone age (BA), and predicted ﬁnal height (PFH) at operation (op). Final height (FH). Means ± SEM. aP<. 001 versus PFH at
operation.
a ne a r l yb o n ea g e .W ef o u n dt h ep r o c e d u r et ob es a f ea n dn o
signiﬁcant side eﬀects were reported.
Weheredocumenttheeﬃcacyandsafetyofepiphysiode-
sis in both girls and boys. Previously the only report of long-
term outcome of this procedure has been in boys. The height
reduction in our male patient group is in agreement with
what was previously reported [15]. We have not only based
our data on auxological measurements but also veriﬁed the
eﬃcacy and safety radiologically. To further strengthen the
accuracy of the ﬁnal height predictions, a validation cohort
was recruited.
In both girls and boys, bilateral percutaneous epiphys-
iodesisreducedthepredictedremaininggrowthfromtimeof
surgery by approximately one third. When reviewing studies
of hormonal treatment, epiphysiodesis seems to be more
eﬃcient in reducing ﬁnal height. In girls treated at a bone
age of 12.5yrs, the height reduction is around 2cm with
hormonal treatment and around 4cm with epiphysiodesis
[6]. In boys treated at a bone age of 14yrs, epiphysiodesis
results in a ﬁnal height reduction by around 6cm whereas
hormonal treatment at this bone age results in no height
reduction at all according to a meta-analysis [6]. Our results
showed that epiphysiodesis was eﬃcient in reducing ﬁnal
height in all patients except for one boy where we believe
his predicted remaining growth was underestimated. This
assumption is based on the fact that the growth of his upper
body(9.0cm)farexceededhisleggrowth(0.9cm)suggesting
that the intervention was indeed eﬀective also in this patient.
With regards to safety, we monitored for short-term side
eﬀects such as postoperative infections, pain, or discomfort
as well as long-term side eﬀects including any hip-knee-
ankle angulations, leg length discrepancies, or abnormal
bodyproportions.Theonlysideeﬀectsreportedweremildto
moderate postoperative pain and one superﬁcial cutaneous
infection. Our ﬁndings are in agreement with a previous
study of epiphysiodesis where no serious side eﬀects were
reported either [15]. Although no serious complications
occurred,itshouldbenotedthatthisisaninvasiveprocedure
in otherwise healthy individuals. Failure of epiphysiodesis
secondary to insuﬃcient ablation of the physis has indeed
been reported by others [18]. Therefore, careful diagnostic
preoperativeevaluationisessential,andthetreatmentshould
be performed in a center of expertise ensuring the long-term
followup. Regarding body proportions, relative sitting height
at ﬁnal height was indeed closer to the normal than before
surgery when being compared to normative tables for the
generalpopulation[19].Thereasonforthisisthattallstature
is usually characterized by relatively long legs [20]. In most
girls, the sitting height percentage remained below the mean
at ﬁnal height. In contrast, most boys had a sitting height
percentage which was above the normative population, and
in two of them this was more pronounced, most likely linked
to the fact that their sitting heights were above the mean
already at the time of surgery. At ﬁnal height, none of the
treated patients expressed dissatisfaction with their body
proportions. However, an increase in relative sitting height is
to be excpected and should be considered before treatment
decision is made. We do not believe that the surgical
treatment will lead to any long-term side eﬀects in contrast
to hormonal treatment for which fear has been raised of
side eﬀects such as reduced fertility [4] and breast cancer
[11, 13]. Other side eﬀects that have been associated with
hormonal treatment, such as hypertension and thrombosis
[11], were not seen in our operated patients. Therefore, we
regard surgery as the treatment of choice in extremely tall
patients with high blood pressure and/or a family history of
venous thrombosis.
Final height predictions are known to be imprecise
estimates of remaining growth. The most widely used
method for prediction of ﬁnal height was devised by Bayley
and Pinneau (BP method). This method is routinely used in
clinical practise [6]. At time of surgery, most of our patients
were in midpuberty with a mean age of 13.1 ±0.9yrsingirls
and 14.1 ± 1.4yrs in boys. A previous study has shown that
the mean height prediction errors (BP method) at these ages
are 0.5 ± 2.2cm in girls (13yrs) and 2.7 ± 2.9cm in boys
(14yrs) [6].
In order to reduce any prediction errors, all X-ray images
werereadbytwoblindedobservers.Inanattempttoquantify
the potential errors of these predictions, we recruited an
untreated reference population of extremely tall females
and males. This validation clearly demonstrated that the
predication errors were so small that we could ignore it when
calculating the eﬃcacy of the treatment. It is important to
point out that the untreated reference group did not diﬀer
signiﬁcantly from the treated group, although not being
randomly selected. It would of course have been optimal
to include a randomized untreated control group, but this
was not possible for technical reasons. Nevertheless, the
eﬃcacy of the operation was conﬁrmed by radiological leg
measurements which is a very reliable method to assess bone
growth.
5. Conclusions
Our data suggest that bilateral percutaneous epiphysiodesis
is an eﬃcient and safe method to reduce adult height in
extremely tall adolescents. The intervention should not be
performed too late, preferably at a bone age not exceeding
twelve and a half years in girls and fourteen years in boys.International Journal of Pediatric Endocrinology 7
Werecommendthatatreatmentdecisionistakenbeforegirls
havereachedaheightof170cmandboys185cm.Hereby,the
expected growth reduction will exceed 5cm as long as the
predicted ﬁnal height is at least 185cm in girls and 200cm
in boys. The patients should preferably have preoperative
evaluation, treatment, and followup in a specialized center
with expertise in pediatric endocrinology and pediatric
orthopaedicsurgery.Furtherstudiesaredesiredtodocument
the eﬃcacy and safety of this relatively new procedure in
larger patient groups.
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